Global Cancer/Tumor Profiling Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Cancer/Tumor Profiling Market to foresee a significant growth in the industry over the upcoming years. The global cancer/tumor profiling market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer/tumor profiling market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer/tumor profiling market.

The next sections of the cancer/tumor profiling market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Application

Clinical Applications
Research Applications

By Technology

Immunoassays
Hybridization
Next-generation Sequencing
Mass Spectroscopy
Other Technologies (Pyrosequencing and Sanger Sequencing)

By Cancer Type

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma Cancer
Other Cancer Types

Product Code: VMR11210449

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Cancer/Tumor Profiling Market
2.2. Global Cancer/Tumor Profiling Market Snapshot

3 . CANCER/TUMOR PROFILING - INDUSTRY ANALYSIS

3.1. Introduction
3.2. Market Drivers of Cancer/Tumor Profiling Market
3.3. Market Restraints of Cancer/Tumor Profiling Market
3.4. Opportunities of Cancer/Tumor Profiling Market
3.5. Trends of Cancer/Tumor Profiling Market
3.6. Porter's Five Force Analysis of Cancer/Tumor Profiling Market
3.7. Cancer/Tumor Profiling Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Application
- 3.7.2 Market Attractive Analysis by Technology
- 3.7.3 Market Attractive Analysis by Cancer Type
- 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

4.1. Cancer/Tumor Profiling Value Chain Analysis
4.2. Cancer/Tumor Profiling Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Cancer/Tumor Profiling Raw Material Manufactures List
- 4.2.3. Price Trend of Cancer/Tumor Profiling Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CANCER/TUMOR PROFILING MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Global Cancer/Tumor Profiling Market Analysis by Application
5.3 Market Analysis of Clinical Applications by Regions
5.4 Market Analysis of Research Applications by Regions

6 . GLOBAL CANCER/TUMOR PROFILING MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Global Cancer/Tumor Profiling Market Analysis by Technology
6.3 Market Analysis of Immunoassays by Regions
6.4 Market Analysis of Hybridization by Regions
6.5 Market Analysis of Next-generation Sequencing by Regions
6.6 Market Analysis of Mass Spectroscopy by Regions
6.7 Market Analysis of Other Technologies (Pyrosequencing and Sanger Sequencing) by Regions

7 . GLOBAL CANCER/TUMOR PROFILING MARKET ANALYSIS BY CANCER TYPE

7.1 Overview by Cancer Type
7.2 Global Cancer/Tumor Profiling Market Analysis by Cancer Type
7.3 Market Analysis of Breast Cancer by Regions
7.4 Market Analysis of Lung Cancer by Regions
7.5 Market Analysis of Colorectal Cancer by Regions
7.6 Market Analysis of Prostate Cancer by Regions
7.7 Market Analysis of Melanoma Cancer by Regions
7.8 Market Analysis of Other Cancer Types by Regions

8 . GLOBAL CANCER/TUMOR PROFILING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview
- 8.3.2. North America Cancer/Tumor Profiling Market Estimate by Country
- 8.3.3. United State
- 8.3.4. Rest of North America
8.4. Europe
- 8.4.1. Overview
- 8.4.2. Europe Cancer/Tumor Profiling Market Estimate by Market Segment
- 8.4.3. Europe Cancer/Tumor Profiling Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7 Rest of Europe
8.5. Asia Pacific
- 8.5.1. Overview
- 8.5.2. Asia Pacific Cancer/Tumor Profiling Market Estimate by Market Segment
- 8.5.3. Asia Pacific Cancer/Tumor Profiling Market Estimate by Country
- 8.5.4. China
- 8.5.5. Japan
- 8.5.6. India
- 8.5.7. Rest of Asia Pacific
8.6. Latin America
- 8.6.1. Overview
- 8.6.2. Latin America Cancer/Tumor Profiling Market Estimate by Market Segment
- 8.6.3. Latin America Cancer/Tumor Profiling Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview
- 8.7.2. Middle East & Africa Cancer/Tumor Profiling Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Cancer/Tumor Profiling Market Estimate by Country
- 8.7.4. Middle East
- 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CANCER/TUMOR PROFILING COMPANIES

9.1. Cancer/Tumor Profiling Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CANCER/TUMOR PROFILING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Illumina Inc. (US)
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. QIAGEN (Germany)
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. NeoGenomics Laboratories Inc. (US)
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. HTG Molecular Diagnostics Inc. (US)
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Genomic Health Inc. (US)
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Caris Life Sciences (US)
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Helomics Corporation (US)
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. NanoString Technologies Inc. (US)
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Sysmex Corporation (Japan)
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Ribomed Biotechnologies Inc. (US)
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Guardant Health Inc. (US)
- 10.13.1. Company Overview
- 10.13.2. Financials
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Foundation Medicine (US)
- 10.14.1. Company Overview
- 10.14.2. Financials
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Roche Diagnostics (Switzerland) (US)
- 10.15.1. Company Overview
- 10.15.2. Financials
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. GenScript Biotech Corporation (China)
- 10.16.1. Company Overview
- 10.16.2. Financials
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Tempus Labs (US)
- 10.17.1. Company Overview
- 10.17.2. Financials
- 10.17.3. Products
- 10.17.4. Recent Developments
10.18. Boreal Genomics Inc (Canada)
- 10.18.1. Company Overview
- 10.18.2. Financials
- 10.18.3. Products
- 10.18.4. Recent Developments
10.19. Perthera (US)
- 10.19.1. Company Overview
- 10.19.2. Financials
- 10.19.3. Products
- 10.19.4. Recent Developments
10.20. Agendia (US)
- 10.20.1. Company Overview
- 10.20.2. Financials
- 10.20.3. Products
- 10.20.4. Recent Developments
10.21. Omniseq (US)
- 10.21.1. Company Overview
- 10.21.2. Financials
- 10.21.3. Products
- 10.21.4. Recent Developments
10.22. Histogene X (Belgium)
- 10.22.1. Company Overview
- 10.22.2. Financials
- 10.22.3. Products
- 10.22.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

11.1. Impact Analysis of Covid-19 Outbreak on the Market
- 11.1.1. Direct Impact on Production
- 11.1.2. Supply Chain and Market Disruption
- 11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies